Henlius Partners With Mabxience On Trastuzumab

Expands Reach To Argentina, Uruguay and Paraguay

09 Apr 2020

• By Akriti Seth

Henlius has struck a deal with Mabxience to market its HLX02 trastuzumab biosimilar in Argentina, Uruguay and Paraguay.

Expansion — Henlius plans to further expand in Europe, the US and Emerging Markets • Source: Shutterstock

More from Deals

More from Business